Em Destaque
Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF-TIMI 48 Trial Fanola CL, et al. J Am Heart Assoc. 2018
EAS Congress 2022 Conference Highlights – Prof. Thomas Vanassche on Lipid-lowering therapies
EAS Congress 2022 Conference Highlights – Prof. Thomas Vanassche on Inflamation
EAS Congress 2022 Conference Highlights – Prof. Thomas Vanassche on Lifestyle & environmental factors
EAS Congress 2022 Conference Highlights – Prof. Thomas Vanassche on Personalised medicine
